Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 231-240 of 409 for breast cancer

Edit search filters
  1. A Study To Evaluate HKI-272 And Capecitabine For HER2-Positive Breast Cancer And Brain Metastases

    Rochester, MN

  2. Wearable EEG Headband As A Meditation Device For Breast Cancer Survivors

    Rochester, MN

  3. Study Of Imprime PGG And Pembrolizumab In Advanced Melanoma And Triple Negative Breast Cancer

    Rochester, MN

  4. Expanded Access Program To Provide Abemaciclib (LY2835219) For The Treatment Of Metastatic Breast Cancer

    Rochester, MN

  5. Investigating Magnesium Glycinate In Structure/Function Role Of Hot Flashes.

    Jacksonville, FL

  6. T-DM1 Vs Paclitaxel/Trastuzumab For Breast

    Rochester, MN

  7. MM-302 Plus Trastuzumab Vs. Chemotherapy Of Physician's Choice Plus Trastuzumab In HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. FES PET/CT In Predicting Response In Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

    Rochester, MN

  9. Olaparib And Atezolizumab Either Alone Or In Combination In Treating Patients With Stage III-IV Triple Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Evaluate Risk/Benefit Of Nab Paclitaxel In Combination With Gemcitabine And Carboplatin Compared To Gemcitabine And Carboplatin In Triple Negative Metastatic Breast Cancer (Or Metastatic Triple Negative Breast Cancer)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer